NCT07163208 Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache
| NCT ID | NCT07163208 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Lahore |
| Condition | Cervicogenic Headache |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-09-05 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-09-05 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study tests if low-level laser therapy (LLLT) with different light wavelengths can help people with cervicogenic headache, a type of headache caused by neck problems. Adults aged 18-65 with this headache for at least 3 months will try one of three LLLT treatments (675nm, 820nm, or a mix of wavelengths) along with regular physical therapy like stretching and exercises. The study will check pain levels, how often headaches happen, neck movement, disability, and quality of life over 6 weeks, with follow-ups at 3 and 6 months. the investigators want to find the best LLLT option to reduce headache symptoms safely.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-65 years diagnosed with cervicogenic headache based on the International Classification of Headache Disorders (ICHD-3) criteria. * Persistent headaches for at least 3 months. * No previous exposure to low-level laser therapy (LLLT). Exclusion Criteria: * Patients with other primary headache disorders (e.g., migraine, tension-type headache). * History of cervical spine surgery. * Pregnant or lactating women. * Patients with a history of photosensitivity or taking photosensitizing medications.
Contact & Investigator
Umair Ahmed, PhD
STUDY DIRECTOR
University of Lahore, Lahore, Pakistan
Frequently Asked Questions
Who can join the NCT07163208 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07163208 currently recruiting?
Yes, NCT07163208 is actively recruiting participants. Contact the research team at arooj.munawar@uipt.uol.edu.pk for enrollment information.
Where is the NCT07163208 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07163208 clinical trial?
NCT07163208 is sponsored by University of Lahore. The principal investigator is Umair Ahmed, PhD at University of Lahore, Lahore, Pakistan. The trial plans to enroll 150 participants.